Defective control of pre-messenger RNA splicing in human disease - Test2 - elhamkhani - TriplyDB

Defective control of pre-messenger RNA splicing in human disease

Defective control of pre-messenger RNA splicing in human disease

http://www.wikidata.org/entity/Q28077564

about

Modulating splicing with small molecular inhibitors of the spliceosome The nuts and bolts of the endogenous spliceosome Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment Structural insights into Gemin5-guided selection of pre-snRNAs for snRNP assembly Mutations in spliceosomal proteins and retina degeneration The notorious R.N.A. in the spotlight - drug or target for the treatment of disease EventPointer: an effective identification of alternative splicing events using junction arrays.Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.Structural studies of the endogenous spliceosome - The supraspliceosome.A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation Splice-switching antisense oligonucleotides as therapeutic drugs The determinants of alternative RNA splicing in human cells.BPP: a sequence-based algorithm for branch point prediction.Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.Variant in the X-chromosome spliceosomal gene GPKOW causes male-lethal microcephaly with intrauterine growth restriction.Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing.RNA splicing during terminal erythropoiesis.Integration of mRNP formation and export.Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.Alternative splicing as a regulator of development and tissue identity.Deep intronic mutations and human disease.The emerging role of alternative splicing in senescence and aging.From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides.Cutting a Long Intron Short: Recursive Splicing and Its Implications.The role of alternative splicing in cancer.RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.Circular RNAs in cancer: opportunities and challenges in the field.Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder.MYC Regulates α6 Integrin Subunit Expression and Splicing Under Its Pro-Proliferative ITGA6A Form in Colorectal Cancer Cells.Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.Exploiting the CRISPR/Cas9 system to study alternative splicing in vivo: application to titin.The TORC1-Regulated CPA Complex Rewires an RNA Processing Network to Drive Autophagy and Metabolic Reprogramming.Molecular basis of titin exon exclusion by RBM20 and the novel titin splice regulator PTB4.ZFR coordinates crosstalk between RNA decay and transcription in innate immunity.Alternative mRNA Splicing in the Pathogenesis of Obesity.Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.Multilevel Differential Control of Hormone Gene Expression Programs by hnRNP L and LL in Pituitary Cells.

P2860

Q26738664-1AFCDB32-89B4-4349-AFE3-9E54BD9F0552 Q26741296-AE955FF5-9F81-4FC0-9553-EFEE162DA21D Q27312184-E5C6D136-17FF-47FB-BB83-C1B9A0FFD7F4 Q28074931-C485C424-81C3-4F3E-8D59-B12B07745F43 Q28116050-D249C5E3-324C-480B-81A8-C196ABE4A3DC Q33739682-0E31BC07-29E4-4931-A3BC-941A7D041915 Q33739733-1F359230-55B5-4E9A-8FC8-F486880C41E6 Q36055662-DC64DEB1-F3F0-4065-8480-8B533AEC1F2E Q36147466-5DE2E7B5-4DC8-49DF-8FAF-C87CBFD8CD96 Q36347782-98D01084-3521-4D7C-9BC2-B5CC4DDE2B75 Q37010219-0A493954-4770-45FD-91D2-AD223912433F Q37211004-8D082776-866A-40CD-ADA2-6B30B6B72C3A Q38679766-EB90CD75-ED8E-427F-9FDC-C83A0100E503 Q38716866-30E3F8FD-F7E0-47DC-9066-7E1DE342EFB9 Q38717741-F5EB2629-2BAC-4EDA-A144-B8E3CA6B82C2 Q38726293-45818621-0AE7-4CFF-B621-00633A2EF468 Q38735423-898C1E45-94B1-473E-BA80-FFEF462F9C54 Q38815706-04EF9DBF-8F82-499B-8C87-F8D958CE2490 Q39101108-811374DC-6BAD-4DE2-83FE-DF9E9915BAD8 Q39185469-605912EC-B675-4031-8AFD-666B586368BF Q39256785-C934949B-7CCE-4278-9927-8309F3514388 Q39295240-D55066E3-031B-443D-8CC6-8A726EADA7A3 Q39301532-A37FE80D-EFC3-4212-9816-AEE27244FF47 Q39432413-5A99E406-B258-4645-BE0F-57909DCF4C8E Q41387647-EAF0413D-4C97-455E-846B-782A01E7E2F1 Q41856429-9DCEEFFC-1C12-41A2-8FF7-93ACC5FC6F05 Q42282317-EFA68C99-56B2-4FAE-A6BE-1C5F14F408F2 Q47129433-FCACCF65-A124-4152-9B6A-AAABC523842D Q47152662-EF6F0D7C-8EA2-4B4E-B493-02E176C25D9B Q47908310-00870083-06B9-43FC-81FC-C3EED49400FD Q47946104-2253E62F-E1DF-4C24-BDB1-378284624636 Q48104981-94880D99-12C6-426C-94C3-3581841BCD85 Q50880824-B8FCF94B-E1FA-4A8E-B9B8-A240CDF9BBE6 Q51148325-0F244E06-45C4-4C9A-BA69-A86E3FDB7BE3 Q52335114-C1ED5697-EDC2-4A1E-B4B4-BD4DAAD24075 Q52666754-8F9C0C43-32F1-4761-B263-C3899F591823 Q54252269-66AF9155-809E-4D4C-A66B-1B354208092B Q54971907-6BDE4D5F-0376-4BB4-910B-0D773D30066B Q54978916-6B75472B-3BCB-41AE-807E-7D5DDD84AD9E Q55114672-72027B39-D5A5-4794-9E9F-E5F0789EC508

P2860

Defective control of pre-messenger RNA splicing in human disease

http://www.wikidata.org/entity/Q28077564

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Defective control of pre-messenger RNA splicing in human disease

@ast

Defective control of pre-messenger RNA splicing in human disease

@en

Defective control of pre-messenger RNA splicing in human disease

@nl

type

label

Defective control of pre-messenger RNA splicing in human disease

@ast

Defective control of pre-messenger RNA splicing in human disease

@en

Defective control of pre-messenger RNA splicing in human disease

@nl

prefLabel

Defective control of pre-messenger RNA splicing in human disease

@ast

Defective control of pre-messenger RNA splicing in human disease

@en

Defective control of pre-messenger RNA splicing in human disease

@nl

P1433

Q28077564-38600650-FBD7-4C95-B741-72A7CEADD79C

P1476

Q28077564-F685DDF5-2BE3-461A-A497-5DFDB2D9B6EB

P2093

Q28077564-266D1FAA-A4AC-48BA-88B0-E2F1DF3B1D03

Q28077564-D45FC8FA-F71C-4618-83AC-293271B5A995

P2860

Q28077564-00E04BD9-43E3-4E47-9DD1-195C90AC9C5C

Q28077564-01CE677B-7795-4500-915B-4CACA8317AA4

Q28077564-028D4F49-B357-4EB7-906B-0EE730DAA2DA

Q28077564-03CA6D33-1D52-442F-950B-0DB2B1D2EA46

Q28077564-05E41382-BB09-4BC1-A708-CB310D68583A

Q28077564-0739E2EC-E6F4-4D7F-B19C-21231335DC42

Q28077564-0AD07B66-D725-4F0A-AB04-0A16DF62B992

Q28077564-10A14D01-AFCF-47CE-B1BC-E77D629C901B

Q28077564-12998D9E-F3AE-4B87-8D07-7B1A2E31F26C

Q28077564-13511444-7743-4B5E-A069-AAA30727D97F

P304

Q28077564-47DFEAA8-3CA1-4106-9CE2-3BA07B45F036

P31

Q28077564-73BD5ACC-C492-4264-908A-D33328D98258

Q28077564-C9299B60-F7D5-473D-8B0B-4280D56701AF

P3181

Q28077564-CA9F62FB-03AC-4CC1-A7AA-FFD855191051

P356

Q28077564-1DEED9A1-78C4-4B7A-A56B-C68769BEF3D7

P407

Q28077564-534AE2C6-D090-476D-8E3E-1C8B649AB986

P433

Q28077564-F311BFE5-C758-48A7-A7F4-29196DF14384

P478

Q28077564-A86CEB67-7D01-44CB-A911-1D5D55EDFA9B

P577

Q28077564-58465B22-27B3-4792-8869-E7C644A1A055

P5875

Q28077564-A302B158-EA2D-4D9C-9EB7-7379584B0B1D

P698

Q28077564-0001023F-82EA-4D29-98FB-DF7473C41F6B

P921

Q28077564-01D909D1-BE75-4942-97B6-E1A05966EDCF

Q28077564-1789DADD-01EA-47CE-AC34-1B55B36C8360

Q28077564-43F99A19-21DA-46A2-AB5A-A2D77203965E

Q28077564-60E947A0-7B93-43EE-94C0-0E294FA1EC1C

Q28077564-F59FAA14-DB76-403C-B7AB-49C77775A15B

P932

Q28077564-64CD732F-E0F8-4B03-80FA-DD09CE43121D

P3181

P356

P1433

Journal of Cell Biology

P1476

Defective control of pre-messenger RNA splicing in human disease

@en

P2093

Benoit Chabot

http://www.w3.org/2001/XMLSchema#string

Lulzim Shkreta

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation

Genome instability and transcription elongation impairment in human cells depleted of THO/TREX

RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion

Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy

Epigenetics in alternative pre-mRNA splicing

Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS

Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain

The RNA Splicing Response to DNA Damage

Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation

P304

13-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

687437

http://www.w3.org/2001/XMLSchema#string

P356

10.1083/JCB.201510032

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

212

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289694216

http://www.w3.org/2001/XMLSchema#string

P698

26728853

http://www.w3.org/2001/XMLSchema#string

P921

transport protein

regulation of gene expression

myelodysplastic syndrome

P932

4700483

http://www.w3.org/2001/XMLSchema#string